|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| C07K 14/52 | (2006.01) |
| (11) | Number of the document | 1675606 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04781153.4 |
| Date of filing the European patent application | 2004-08-13 | |
| (97) | Date of publication of the European application | 2006-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-05 |
| (46) | Date of publication of the claims translation | 2017-11-10 |
| (86) | Number | PCT/US2004/026422 |
| Date | 2004-08-13 |
| (87) | Number | WO 2005/023834 |
| Date | 2005-03-17 |
| (30) | Number | Date | Country code |
| 498740 P | 2003-08-28 | US |
| (72) |
MACDONALD, Brian, R., US
WEIS, Jeffery, Kenneth, US
YURKOW, Edward, John, US
|
| (73) |
Janssen Pharmaceuticals, Inc.,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Peptidai ir junginiai, kurie jungiasi prie trombopoetino receptorių |
| PEPTIDES AND COMPOUNDS THAT BIND TO THROMBOPOIETIN RECEPTORS |
| Payment date | Validity (years) | Amount | |
| 2022-08-05 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-08-13 |